Sign in
4

Changes in Ownership

Verrica Pharmaceuticals Inc. Filed Acc 0001209191-23-036149

Options or other derivatives

  • Director acquired 10,384 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Eichenfield Lawrence Director 2023-06-08 Grant or award · Stock Option (right to buy) +10,384 10,384 D: show line 1 in the form
Loading xslF345X04/doc4.xml…